GAPDH and human African trypanosomiasis: Using kinetic modelling and MCA, Bakker et al. [83] have demonstrated that glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate kinase may represent promising targets for the treatment of sleeping sickness due to drastically different susceptibility of glycolytic fluxes to inhibition of these enzymes in human and in African trypanosome.